Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Inventory Average (2021 - 2026)

Bioventus filings provide 5 years of Inventory Average readings, the most recent being $89.3 million for Q4 2025.

  • On a quarterly basis, Inventory Average fell 2.19% to $89.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $89.3 million, a 2.19% decrease, with the full-year FY2025 number at $87.4 million, down 4.95% from a year prior.
  • Inventory Average hit $89.3 million in Q4 2025 for Bioventus, down from $96.4 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $96.9 million in Q3 2023 to a low of $34.5 million in Q2 2021.
  • Median Inventory Average over the past 5 years was $89.0 million (2024), compared with a mean of $77.5 million.
  • Biggest five-year swings in Inventory Average: surged 106.89% in 2022 and later dropped 8.36% in 2024.
  • Bioventus' Inventory Average stood at $49.1 million in 2021, then soared by 64.59% to $80.9 million in 2022, then grew by 16.81% to $94.4 million in 2023, then fell by 3.38% to $91.3 million in 2024, then fell by 2.19% to $89.3 million in 2025.
  • The last three reported values for Inventory Average were $89.3 million (Q4 2025), $96.4 million (Q3 2025), and $95.3 million (Q2 2025) per Business Quant data.